The financials
Zimmer Biomet by the numbers
Zimmer Biomet (ZBH) reported revenue of $2.09B in Q1 2026 (quarter ended March 31, 2026), up 9.3% from the same quarter a year earlier. That came with a gross margin of 72% and net income of $238M (11% of revenue). For the full year FY2025, revenue was $8.23B (+7.2% year on year) and net income $705M. Its largest product in 2026-Q1 was Knees at $829M, 40% of the disclosed total, just ahead of SET at 27%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $2.09B | $1.91B | +9.3% |
| Gross profit | $1.51B | $1.36B | +11% |
| Operating income | $373M | $292M | +28% |
| Net income | $238M | $182M | +31% |
| Diluted EPS | $1.22 | $0.91 | +34% |
| Product | Revenue | Share |
|---|---|---|
| Knees | $829M | 40% |
| SET | $562M | 27% |
| Hips | $524M | 25% |
| Technology And Data Bone Cement And Surgical | $172M | 8.2% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $2.09B (+4.3%)
SET grew +19% year on yearKnees +4.5% year on year
Segment Latestquarter on quarteryear on year
- Knees$828.6M$828.6MQoQ +4.6%year on year +4.5%+4.6%+4.5%
- SET$562.2M$562.2MQoQ +3.8%year on year +19%+3.8%+19%
- Hips$524.1M$524.1MQoQ +3.5%year on year +5.7%+3.5%+5.7%
- Technology And Data Bone Cement And Surgical$171.8M$171.8MQoQ +6.5%year on year +15%+6.5%+15%
Medical Devices
Ranks #14 of 35 by Smart Score